or Try an Advanced Search...

    Technical Analysis for NVRO - Nevro Corp.

    Grade Last Price % Change Price Change
    F 10.65 -6.74% -0.77
    NVRO closed up 0.88 percent on Monday, April 29, 2024, on 80 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NVRO trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -6.74%
    Inside Day Range Contraction -6.74%
    Lower Bollinger Band Touch Weakness -6.74%
    Oversold Stochastic Weakness -6.74%
    New 52 Week Closing Low Bearish -5.92%
    Lower Bollinger Band Walk Weakness -5.92%
    New 52 Week Low Weakness -5.92%
    Stochastic Reached Oversold Weakness -5.92%
    Below Lower BB Weakness -5.92%
    Down 3 Days in a Row Weakness -5.92%
    Older End-of-Day Signals for NVRO ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 1 hour ago
    Down 5% about 2 hours ago
    60 Minute Opening Range Breakdown about 3 hours ago
    Down 3% about 3 hours ago
    Fell Below Lower Bollinger Band about 5 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NVRO Chart by TradingView
    Basic chart:

    Profile

    Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain. It provides Senza system, a spinal cord stimulation system that delivers its proprietary HF10 therapy. The company was founded in 2006 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Pain Neuroscience Chronic Pain Pain Management Neuromodulation Neurophysiology Neurotechnology Spinal Cord Treatment Of Chronic Pain Nociception

    Is NVRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
    Mar 25 Abbott (ABT) Expands in Canada With First Eterna SCS Use
    Mar 21 Here's Why You Should Retain Nevro (NVRO) Stock for Now
    Feb 29 Nevro (NVRO) Gets FDA Nod for SI Fixation Without Lateral Screw
    Feb 28 FDA clears Nevro SI joint device without need for lateral screw
    Feb 28 Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
    Feb 22 Why Nevro Stock Lagged the Market on Thursday
    Feb 22 Oppenheimer cuts Nevro to perform, cites weakness in core business
    Feb 22 Nevro Corp. (NYSE:NVRO) Q4 2023 Earnings Call Transcript
    Feb 22 Nevro's (NVRO) Q4 Earnings and Sales Top Estimates, Margins Up
    See more NVRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.89
    52 Week Low 11.26
    Average Volume 462,355
    200-Day Moving Average 17.72
    50-Day Moving Average 13.87
    20-Day Moving Average 12.62
    10-Day Moving Average 12.13
    Average True Range 0.64
    RSI (14) 33.33
    ADX 23.35
    +DI 18.08
    -DI 28.72
    Chandelier Exit (Long, 3 ATRs) 12.77
    Chandelier Exit (Short, 3 ATRs) 13.19
    Upper Bollinger Bands 13.89
    Lower Bollinger Band 11.35
    Percent B (%b) 0.03
    BandWidth 20.10
    MACD Line -0.66
    MACD Signal Line -0.60
    MACD Histogram -0.0602
    Fundamentals Value
    Market Cap 414.15 Million
    Num Shares 36.3 Million
    EPS -2.87
    Price-to-Earnings (P/E) Ratio -3.98
    Price-to-Sales 1.50
    Price-to-Book 2.18
    PEG Ratio -3.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.95
    Resistance 3 (R3) 11.98 11.84 11.86
    Resistance 2 (R2) 11.84 11.71 11.82 11.83
    Resistance 1 (R1) 11.63 11.62 11.56 11.60 11.80
    Pivot Point 11.49 11.49 11.46 11.47 11.49
    Support 1 (S1) 11.28 11.36 11.21 11.25 11.04
    Support 2 (S2) 11.14 11.27 11.12 11.01
    Support 3 (S3) 10.93 11.14 10.98
    Support 4 (S4) 10.90